COVID-19 in rheumatology

COVID-19, caused by the coronavirus SARS-CoV-2, impacts patients with rheumatic diseases in several ways. These patients often have weakened immune systems due to their conditions or medications, making them more susceptible to severe illness. Managing rheumatic diseases during the pandemic requires careful consideration of treatments that may affect immune responses. Additionally, individuals with these conditions may face challenges related to access to healthcare and maintaining their treatment regimens while avoiding infections. Understanding the balance between managing their disease and protecting themselves from COVID-19 is crucial for this patient population.